Recommended Treatment for Lupus Nephritis
Links shared publicly online about this topic
Lupus Nephritis on #MDlinx
mdlinx.com — “Lupus Nephritis on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 22, 2010 at 11:42 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Mycophenolate mofetil for induction treatment of lupus nephritis: A systematic review and metaanalysi... http://bit.ly/bu4l7L #Rheumatology
Rheumatology Article | Lupus Nephritis
mdlinx.com — “Longterm followup after tapering mycophenolate mofetil during maintenance treatment for proliferative lupus nephritis” View full resource at mdlinx.com
Most Recently Shared on April 20, 2011 at 8:05 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Longterm followup after tapering mycophenolate mofetil during maintenance treatment for proliferat... http://bit.ly/gTSFpW #Rheumatology
Study: Mycophenolate Is Superior To Azathioprine As Treatment For Lupus Nephritis
medicalnewstoday.com — “A new large, international study finds that the immunosuppressant drug mycophenolate mofetil is superior to azathioprine, an older immunosuppressant, as a maintenance therapy for lupus nephritis.” View full resource at medicalnewstoday.com
Most Recently Shared on November 17, 2011 at 11:05 am By:
MNT Neurology News Neurology and Health News
Study: Mycophenolate Is Superior To Azathioprine As Treatment For Lupus Nephritis http://t.co/0wnNkP5G #neurology
Rituximab Eases Lupus Nephritis - Renal and Urology News
renalandurologynews.com — “Rituximab is an effective treatment for lupus nephritis that enables reductions in maintenance steroids, data show.” View full resource at renalandurologynews.com
Most Recently Shared on September 21, 2009 at 6:28 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
Rituximab Eases Lupus Nephritis: Rituximab is an effective treatment for lupus nephritis that enables reductions.. http://bit.ly/3rQMjj
Rheumatology Medical News about Lupus Nephritis Tacrolimus
mdlinx.com — “Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis” View full resource at mdlinx.com
Most Recently Shared on June 29, 2010 at 11:10 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis: Lupus http://bit.ly/9egquK #Rheumatology
Classification and treatment of Lupus Nephritis : Nephrology On-Demand
blog.ecu.edu — “Classification and treatment of Lupus Nephritis : Nephrology On-Demand” View full resource at blog.ecu.edu
Most Recently Shared on July 27, 2011 at 2:57 pm By:
Nephrology On-Demand Medical Journal and Nephrology
New: Classification and treatment of Lupus Nephritis http://bit.ly/ra7EMw
Immune cell's role in lupus nephritis demonstrated
physorg.com — “National Institutes of Health scientists have discovered that the activation of immune cells called basophils causes kidney damage in a mouse model of lupus nephritis. These findings and the team's associated research in humans may lead to new treatments for this serious disease, a severe form of systemic ...” View full resource at physorg.com
Most Recently Shared on June 1, 2010 at 2:16 pm By:
PhysOrg Health News Health News
Immune cell's role in lupus nephritis demonstrated http://tw.physorg.com/194606140
Immune cell's role in lupus nephritis demonstrated
eurekalert.org — “National Institutes of Health scientists have discovered that the activation of immune cells called basophils causes kidney damage in a mouse model of lupus nephritis. These findings and the team's associated research in humans may lead to new treatments for this serious disease, a severe form of systemic lupus erythematosus that affects the kidneys and is difficult to treat.” View full resource at eurekalert.org
Most Recently Shared on June 2, 2010 at 6:48 pm By:
Activated basophils and IgE antibodies implicated in an animal model of lupus. http://bit.ly/9df23F
Rheumatology Medical News about Lupus Erythematosus, Systemic Lupus Nephritis
mdlinx.com — “Use of rituximab in the treatment of refractory systemic lupus erythematosus: Singapore experience” View full resource at mdlinx.com
Most Recently Shared on May 6, 2010 at 12:07 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Use of rituximab in the treatment of refractory systemic lupus erythematosus: Singapore experience: Lupus http://bit.ly/bYVNQn #Rheumatology
Mouse Model Demonstrates The Immune Cell's Role In Lupus Nephritis
medicalnewstoday.com — “National Institutes of Health scientists have discovered that the activation of immune cells called basophils causes kidney damage in a mouse model of lupus nephritis. These findings and the team'” View full resource at medicalnewstoday.com
Most Recently Shared on June 2, 2010 at 11:00 am By:
Mouse Model Demonstrates The Immune Cell's Role In Lupus Nephritis http://w.sns.ly/hzp44
Lupus Foundation Of America Says Results Of Latest Study Of CellCept Provide Encouragement And Hope For People With Lupus Nephritis
medicalnewstoday.com — “The Lupus Foundation of America praised the results of a new long-term study for the treatment of lupus nephritis (lupus-related kidney disease) which demonstrated superiority of CellCept® (my” View full resource at medicalnewstoday.com
Most Recently Shared on June 6, 2010 at 11:06 am By:
Lupus Foundation Of America Says Results Of Latest Study Of CellCept Provide Encouragement And Hope For People Wi... http://w.sns.ly/H0G48
Rheumatology Medical News about Lupus Nephritis Tacrolimus; mycophenolate mofetil
mdlinx.com — “Long-term outcomes - mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases” View full resource at mdlinx.com
Most Recently Shared on June 25, 2010 at 7:15 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Long-term outcomes - mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus ... http://bit.ly/9uoNDv #Rheumatology
'Multi-target' immune therapy improves outcomes of severe lupus nephritis
eurekalert.org — “A new treatment using a combination of drugs targeting different parts of the immune system improves the recovery rate for patients with severe lupus involving the kidneys, according to a report in the October Journal of the American Society of Nephrology.” View full resource at eurekalert.org
Most Recently Shared on July 2, 2008 at 4:23 am By:
AAAS 'Multi-target' immune therapy improves outcomes of severe lupus nephritis http://tinyurl.com/3n972m
Advisers recommend Human Genome lupus drug | Reuters
reuters.com — “ADELPHI, Maryland (Reuters) - The first new lupus treatment in half a century moved closer to U.S. approval on Tuesday as an advisory panel endorsed a potential blockbuster medicine from Human Genome Sciences” View full resource at reuters.com
Most Recently Shared on November 17, 2010 at 1:46 am By:
Advisers recommend Human Genome lupus drug: ADELPHI, Maryland (Reuters) - The first new lupus treatment in half ... http://bit.ly/ceu2Eg
Advisers recommend Human Genome lupus drug | Reuters
reuters.com — “ADELPHI, Maryland (Reuters) - The first new lupus treatment in half a century moved closer to U.S. approval on Tuesday as an advisory panel endorsed a potential blockbuster medicine from Human Genome Sciences” View full resource at reuters.com
Most Recently Shared on November 17, 2010 at 1:41 am By:
Advisers recommend Human Genome lupus drug http://dlvr.it/8fsfd
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
MNT Neurology News
The latest neurology / neuroscience news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
